Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574956 | 1.00 | MAOB (0.68) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL12992717 | 1.00 | MAOB (0.68) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL19956847 | 0.90 | MAOB (0.70) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL135524 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL5875512 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL23458007 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL592744 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL9803304 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL6853572 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL718317 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537853-A1 | Use of a composition comprising a compound comprising a lacton ring and/or a corresponding coloring agent with an open ring for dyeing keratinuous fibers | L'OREAL (FR) | 2005-06-08 | — | — | EP | claimed |
| US-20230276693-A1 | LIGHT-EMITTING DEVICE, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND MIXTURE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-31 | — | — | US | disclosed |
| US-20230048387-A1 | CORROSION PROTECTION METHOD FOR WELLBORE PIPING | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-02-16 | — | — | US | disclosed |
| US-20190084941-A1 | COMPOUNDS AND METHODS OF TREATING INFECTIONS | NEOCULI PTY LTD (AU) | 2019-03-21 | — | — | US | disclosed |
| US-7244851-B2 | 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies | GENENTECH, INC. (US) | 2007-07-17 | — | — | US | disclosed |
| EP-1537853-A1 | Use of a composition comprising a compound comprising a lacton ring and/or a corresponding coloring agent with an open ring for dyeing keratinuous fibers | L'OREAL (FR) | 2005-06-08 | — | — | EP | disclosed |
| WO-2001098313-A1 | CARBON DIOXIDE SEQUESTRATION BY COBALT (II) COMPLEXES | LATTICE INTELLECTUAL PROPERTY LTD (GB) | 2001-12-27 | — | — | WO | disclosed |
| CN-1295071-A | Condensed imidezo-[1,2-a] pyridines | NEW JAPAN MEDICINE CO LTD (JP) | 2001-05-16 | — | — | CN | disclosed |
| CN-1064360-C | Fused imidazo [1, 2-a ] pyridines | SHINIPPON PHARMACEUTICAL INC (JP) | 2001-04-11 | — | — | CN | disclosed |
| US-6103736-A | SHOWING AN INHIBITORY ACTION ON GASTRIC ACID SECRETION AND A PROTECTIVE ACTION OF GASTRIC MUCOSA; 2-(HETERO)ARYL-3-AMINOIMIDAZO-(2,1-A)ISOQUINOLINES; ANTIULCER AGENTS; | SHINNIPPON PHARMACEUTICAL INC. (JP) | 2000-08-15 | — | — | US | disclosed |
| US-6020342-A | Fused imidazo[1,2-A]pyridines | SHINNIPPON PHARMACEUTICAL, INC. (JP) | 2000-02-01 | — | — | US | disclosed |
| CN-1182428-A | Fused imidazo [1, 2-alpha ] pyridines | SHINNIPPON PHARMACEUTICAL INC (JP) | 1998-05-20 | — | — | CN | disclosed |
| EP-0822194-A1 | FUSED IMIDAZO 1,2-a]PYRIDINES | Shinnippon Pharmaceutical Inc. (JP) | 1998-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190084941-A1 | COMPOUNDS AND METHODS OF TREATING INFECTIONS | ELANE, IL1A, IL1B | MAOB 641/4885MAPK1 1453/4885ALDH1A1 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.